Plasma Angiotensin II Is Increased in Critical Coronavirus Disease 2019

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) employs angiotensin-converting enzyme 2 (ACE2) as its receptor for cell entrance, and studies have suggested that upon viral binding, ACE2 catalytic activity could be inhibited; therefore, impacting the regulation of the renin-angiotensin-...

Descripción completa

Detalles Bibliográficos
Autores principales: Camargo, Rafael L., Bombassaro, Bruna, Monfort-Pires, Milena, Mansour, Eli, Palma, Andre C., Ribeiro, Luciana C., Ulaf, Raisa G., Bernardes, Ana Flavia, Nunes, Thyago A., Agrela, Marcus V., Dertkigil, Rachel P., Dertkigil, Sergio S., Araujo, Eliana P., Nadruz, Wilson, Moretti, Maria Luiza, Velloso, Licio A., Sposito, Andrei C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263116/
https://www.ncbi.nlm.nih.gov/pubmed/35811697
http://dx.doi.org/10.3389/fcvm.2022.847809

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263116/
https://www.ncbi.nlm.nih.gov/pubmed/35811697
http://dx.doi.org/10.3389/fcvm.2022.847809

Ejemplares similares